#liminatus-pharma
Latest news and interesting information about liminatus-pharma.
Liminatus Pharma Faces Nasdaq Delisting
Liminatus Pharma gets Nasdaq delisting notice after failing to meet market value requirements. Stock down 95.5%.
...
→
EN ▾
GYG exits US market retreatGolden Rule Against Hair Loss from DietitianPalladyne AI CLO sells $32,225 in stockArafura Plans $250 Million Share SaleNorth Carolina sues Vietnam's Vinfast over delayed EV projectPalladyne AI CFO sells $28,022 in stockPalladyne AI CTO Sells $105,529 in StockFold CTO Sells $97 in StockCapital V LLC sells $403k in Viant class A sharesStocks rise, dollar at six-week highGYG exits US market retreatGolden Rule Against Hair Loss from DietitianPalladyne AI CLO sells $32,225 in stockArafura Plans $250 Million Share SaleNorth Carolina sues Vietnam's Vinfast over delayed EV projectPalladyne AI CFO sells $28,022 in stockPalladyne AI CTO Sells $105,529 in StockFold CTO Sells $97 in StockCapital V LLC sells $403k in Viant class A sharesStocks rise, dollar at six-week high